Evidence map›Paper›PMID 33961680›Full record

ArticlePLoS pathogens2021

Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques.

Matthew P Wood, Chloe I Jones, Adriana Lippy, Brian G Oliver, Brynn Walund, Katherine A Fancher, Bridget S Fisher, Piper J Wright, James T Fuller, Patience Murapa and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Matthew P WoodCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Chloe I JonesCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0001-9304-5168
Adriana LippyCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Brian G OliverCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Brynn WalundCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0001-6432-8046
Katherine A FancherCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0002-2719-1797
Bridget S FisherCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Piper J WrightCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
James T FullerUniversity of Washington Department of Microbiology, Seattle, Washington, United States of America.
Patience MurapaUniversity of Washington Department of Microbiology, Seattle, Washington, United States of America.ORCID 0000-0002-5824-9672
Jakob HabibYerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-8720-8757
Maud MavignerYerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Ann ChahroudiYerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0001-7479-9546
D Noah SatherCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0002-9128-172X
Deborah H FullerUniversity of Washington Department of Microbiology, Seattle, Washington, United States of America.ORCID 0000-0001-7315-2441
Donald L SodoraCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.ORCID 0000-0002-8927-052X
Infectious Disease Research Institute · USEmory University · USUniversity of Washington · US

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Immune interventions in SIV-infected ART-suppressed infant macaquesR01AI133706 · NIAID · EMORY UNIVERSITY · PI CHAHROUDI, ANN M · 2017 to 2021
$4.1M
Harnessing oral mucosa vaccination to drive protective HIV antibody responsesR01DE026336 · NIDCR · SEATTLE CHILDREN'S HOSPITAL · PI SATHER, D. NOAH, SODORA, DONALD L · 2016 to 2020
$4.1M
Risk of Neonatal Vaccination for HIV/SIV Exposed InfantsR01DE023047 · NIDCR · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SODORA, DONALD L · 2013 to 2016
$3.5M
NIAID NIH HHS R01 AI133706NIAID NIH HHS T32 AI007509NIDCR NIH HHS R01 DE023047NIDCR NIH HHS R01 DE026336
6 · The paper itself

Abstract

HIV-infected infants are at an increased risk of progressing rapidly to AIDS in the first weeks of life. Here, we evaluated immunological and virological parameters in 25 SIV-infected infant rhesus macaques to understand the factors influencing a rapid disease outcome. Infant macaques were infected with SIVmac251 and monitored for 10 to 17 weeks post-infection. SIV-infected infants were divided into either typical (TypP) or rapid (RP) progressor groups based on levels of plasma anti-SIV antibody and viral load, with RP infants having low SIV-specific antibodies and high viral loads. Following SIV infection, 11 out of 25 infant macaques exhibited an RP phenotype. Interestingly, TypP had lower levels of total CD4 T cells, similar reductions in CD4/CD8 ratios and elevated activation of CD8 T cells, as measured by the levels of HLA-DR, compared to RP. Differences between the two groups were identified in other immune cell populations, including a failure to expand activated memory (CD21-CD27+) B cells in peripheral blood in RP infant macaques, as well as reduced levels of germinal center (GC) B cells and T follicular helper (Tfh) cells in spleens (4- and 10-weeks post-SIV). Reduced B cell proliferation in splenic germinal GCs was associated with increased SIV+ cell density and follicular type 1 interferon (IFN)-induced immune activation. Further analyses determined that at 2-weeks post SIV infection TypP infants exhibited elevated levels of the GC-inducing chemokine CXCL13 in plasma, as well as significantly lower levels of viral envelope diversity compared to RP infants. Our findings provide evidence that early viral and immunologic events following SIV infection contributes to impairment of B cells, Tfh cells and germinal center formation, ultimately impeding the development of SIV-specific antibody responses in rapidly progressing infant macaques.

Indexed as

Disease ProgressionImmunity, HumoralAnimalsB-LymphocytesGenetic VariationGerminal CenterHumansInterferon Type ILymphoid TissueMacaca mulattaPhenotypeSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViral LoadInterferon Type I

Identifiers

PMID33961680
PMCPMC8133453
OpenAlexW3159380101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.